Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program -HUNTSVILLE, AL, ...
Siren plans to initiate a first-in-human clinical study in adult patients with recurrent high-grade glioma. This advancement builds on the Company’s broader Universal AAV Immuno-Gene Therapy platform, ...
Zacks Investment Research on MSN
NTLA stock up more than 6% as FDA lifts ATTRv-PN study clinical hold
Intellia Therapeutics NTLA announced that the FDA lifted the clinical hold on the investigational new drug application (IND) ...
The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...
The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...
IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...
The FDA cleared the investigational new drug (IND) application for a global phase 3 registrational trial of iSCIB1 +, a DNA plasmid vaccine, in patients with advanced melanoma, scheduled to commence ...
A New Approach Enabling Physicians to Treat Toenail Fungus at the Point-of-Care HSG 42 is highly differentiated. It is ...
Scancell Holdings plc (AIM: SCLP), the developer of active immunotherapies to treat cancer, announces the U.S. Food a ...
“Let it grow, let it blossom,” said Eric Clapton, and so the Food and Drug Administration expects of expanded access programs with the issuance of its guidance on “Expanded Access to Investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results